Biocon chief bats for dual-agency model to fast-track drug approvals

Biocon's Kiran Mazumdar-Shaw suggests a new drug approval system. The Indian Council of Medical Research would handle scientific reviews for new drugs and devices. The Central Drugs Standard Control Organisation would then grant final regulatory approval. This aims to speed up innovation and research in India's biotechnology sector.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bF3Gr5p
via IFTTT